This webinar was originally broadcast on Wednesday, February 10, 2010 at 10:00am CST.
Download the Slides
About this Webcast
The U.S. biotechnology industry raised a record $55 billion in 2009 through public and private partnerships and financing. But how much of that money ultimately will result in drugs and other medical therapies used by hospitals, physicians and other practitioners to treat patients?
Attend this webcast and you'll hear from two biotechnology experts who will answer this question and many more. Learn about designer drugs and their implications, as well as the drivers behind biotechnology, including:
- The role of payers and providers
- Bringing genomics to the hospital bedside
- The connection between personalized medicine and biotechnology
Featured Speakers
Paul Billings, M.D.Acting Director and Chief Science OfficerEl Camino Hospital Genomic Medicine InstituteMountain View, CA
Trish BrownVice President of Clinical AffairsDNA DirectSan Francisco, CA
Rebecca VeselyModeratorModern Healthcare
Brought to you by
Modern Healthcare